Navigation Links
Study Published in PLOS ONE Highlights Improved Asthma Control and Fewer Symptoms After Using Asthmapolis System
Date:3/5/2013

MADISON, Wis., March 5, 2013 /PRNewswire/ -- Asthmapolis today announced an investigation featuring the system in the remote monitoring of inhaled bronchodilator use and weekly feedback about asthma management has been published in the latest issue of the scientific journal PLOS ONE (http://dx.plos.org/10.1371/journal.pone.0055335). The study found improved asthma control and a decline in day-to-day asthma symptoms for participants receiving Asthmapolis' weekly email reports and online charts summarizing inhaler use and location.

First author on the report is David Van Sickle , PhD, CEO and Asthmapolis co-founder, with contributors Sheryl Magzamen , PhD, MPH, and Shaun Truelove , MPH, from the University of Wisconsin-Madison School of Medicine and Public Health, Department of Population Health Sciences, and Teresa Morrison , MD, MPH, from the Centers for Disease Control and Prevention, National Center for Environmental Health, Air Pollution and Respiratory Health Branch in Atlanta.

Asthmapolis is an FDA-cleared mobile health solution designed to improve the care of people with asthma, advance understanding of symptoms and triggers and help them achieve control of the disease. Asthmapolis uses a novel combination of smartphone applications and snap-on sensors that track when and how often patients use their inhaled medications. The platform, available in both English and Spanish, is designed to help individuals stick with their daily preventive medications, reveal insights about their use of rescue medications and provide personalized feedback, targeted education and other tools that improve their ability to successfully manage the disease.

Through this open-group short-term pilot study, the researchers sought to
'/>"/>

SOURCE Asthmapolis
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Debunks Wastage Myths of Prescriptions Filled in Medicare Part D
2. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
3. NeuroDerm Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinsons Disease
4. Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology
5. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
6. New Study Shows Cannabis Effects on Driving Skills
7. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
8. University Hospitals Case Medical Center Presents Study On The Elimination Of Retained Surgical Sponges
9. MD+DI, the Global MedTech Authority, Publishes One-of-a-Kind Study with ITG Market Research on the Medical Device Outsourcing Landscape
10. New Direct-to-Consumer Prescription Delivery Channel Mitigates Risk of Medication Non-Adherence Highlighted in JAMA Internal Medicine Study
11. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Vermillion, ... on gynecologic disease, announced today it will ... after the market close on Thursday, August ... call and webcast at 4:30pm Eastern.Conference Call ... at 4:30pm Eastern/1:30pm Pacific  Domestic: ...
(Date:7/30/2015)... VIEJO, Calif. , July 30, 2015 /PRNewswire/ ... aspiring to eliminate all preventable hospitalization, recently received ... that its Remote Patient Intelligence (RPI) solution meets ... the FDA intends to exercise "Enforcement Discretion." ... "are not subject to further FDA regulatory requirements ...
(Date:7/30/2015)... What can be expected from the ... grow at the fastest rates? Visiongain ,s brand ... data, trends, opportunities and prospects there. Our ... graphs. Discover the most lucrative areas in the industry ... you assess forecasted sales at overall world market and ...
Breaking Medicine Technology:FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... Nov. 11 Pharma market research thought leaders are discovering ... opportunities in the pharmaceutical industry. The last twelve months ... Pharmaceutical market research is no exception. But those ... information today will certainly rise to be the new leaders ...
... VVUS ) today announced that Timothy Morris, chief financial officer, ... Markets 6th Annual Healthcare Conference. , The VIVUS presentation will take ... November 18, 2009 at 1:45 p.m. ET. A live webcast ... http://ir.vivus.com . , About VIVUS ...
Cached Medicine Technology:Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research 2VIVUS to Present at Lazard Capital Markets Healthcare Conference 2
(Date:7/30/2015)... WASHINGTON (PRWEB) , ... July 30, 2015 , ... ... the scientific program at ATA’s 21st Annual Meeting and Tradeshow focused exclusively on ... more than 300 cutting-edge health care technology vendors, will take place May 14-17, ...
(Date:7/30/2015)... County, CA (PRWEB) , ... July 30, 2015 , ... ... County, Los Angeles, Riverside, and San Bernardino, recently announced that the Centers for Medicare ... new rating system of home health care providers. 24/7 Care At Home’s agency is ...
(Date:7/30/2015)... ... ... Ross A. Clevens, MD, FACS has been reappointed by the University ... This is Dr. Clevens’ second appointment by the prestigious school. Over the past ... and a valuable mentoring program for medical students. , The University ...
(Date:7/30/2015)... Los Angeles, California (PRWEB) , ... July 30, 2015 , ... ... of the success of the 2015 Special Olympics World Games, the largest sports and ... Angeles since the 1984 Olympic Games. , The World Games, held July 25 through ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Ocean Hills ... available, including the very rare “no recommendations.” No recommendations means CARF found no areas ... is a notation that less than 3% of all facilities receive. In addition, Ocean ...
Breaking Medicine News(10 mins):Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2
... City of Hope leads study showing efficacy of ... ... National,Marrow Donor Program (NMDP) has selected an abstract written by Dr.,Auayporn Nademanee, ... City of Hope, and Dr. Robert Chow,Founder and Global Medical Director for ...
... World Diabetes Day, November 14,is observed every year ... by others with an interest in diabetes. This year,s ... excellent opportunity,to focus on the significant increase in type ... Funded by the National Institutes of Health (NIH), researchers ...
... Percent of People with ... (Spinal Arthritis), ABBOTT PARK, Ill., Nov. 8 A ... decrease in the rate of uveitis flares by approximately half ... of the spine, and may also be associated with other ...
... Corporation,(Nasdaq: RGEN ) today reported results for the ... Total revenue for the quarter was,$5,352,000 compared to $2,865,000 ... 30, 2006, an increase of $2,487,000 or 87%. Total,revenue ... revenue.,Gross profit on product revenue for the second quarter ...
... IDMI ) today announced its financial results for ... information presented,represents the consolidated results of IDM Pharma and ... $33.2 million as of September 30,2007 compared to $37.3 ... 31, 2006. The Company,s net cash outflow from operations ...
... health diagnosis at the point-of-care and begin triage faster and easier ... ... UNION CITY, Calif., Nov. 8 Abaxis, Inc.,(Nasdaq: ABAX ), ... the U.S. Food and Drug,Administration (FDA) has granted waived status under ...
Cached Medicine News:Health News:Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program 2Health News:Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program 3Health News:Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program 4Health News:World Diabetes Day Spotlights Type 1 Diabetes Increase and World Class Response 2Health News:World Diabetes Day Spotlights Type 1 Diabetes Increase and World Class Response 3Health News:Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab) 2Health News:Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab) 3Health News:Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab) 4Health News:Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab) 5Health News:Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab) 6Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 2Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 3Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 4Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 5Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 6Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 7Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 2Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 3Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 4Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 5Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 6Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 7Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 8Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 9Health News:IDM Pharma Reports Third Quarter 2007 Financial Results 10Health News:Abaxis Announces First Ever CLIA-Waived Comprehensive Metabolic Panel 2Health News:Abaxis Announces First Ever CLIA-Waived Comprehensive Metabolic Panel 3Health News:Abaxis Announces First Ever CLIA-Waived Comprehensive Metabolic Panel 4
... new Oculus Easygraph is a corneal ... tools you need for refractive surgery, ... therapy contact lens fitting in a ... 4" package. All you need to ...
The only ergonomic work station of its kind with an optional built-in keratograph and flat-screen. The Concepta is a modern workstation for the examination and refraction of patients....
The natural look of 3 in 1 technology in virtually any prescription....
Dot matrix pattern for light eyed patients....
Medicine Products: